This information is for research and educational purposes only. No medical recommendations. Products are not approved for human use. For health questions, consult a doctor.

Lexicon

Cortagen

A Khavinson cytogen peptide aimed at the brain cortex and nervous system.

3 min read 11 sources

Vial with white powder, a blue cap and a black TPD label for Cortagen on a white podium, next to it a chain of blue and white glass spheres as a molecule model in a bright lab
No registered trial · not approved

Summary

At a glance

Sources checked on 26 Oct 2026

Length
4 amino acids

Ala-Glu-Asp-Pro, derived from the brain cortex extract Cortexin2

Nerve conduction
+40 %

faster conduction in the regrowing sciatic nerve after it was cut, rats3

Changed gene activity
1.53 %

234 of 15,247 sequences in the heart, mice, 5 days2

Human trials in the registry
0 trials

no trial with Cortagen on ClinicalTrials.gov, as of 26 Oct 202610

  • Cortagen is the tetrapeptide Ala-Glu-Asp-Pro. It was designed from the amino acid analysis of Cortexin (a peptide extract from the brain cortex) and belongs to the Khavinson cytogens.211
  • In rat tissue cultures it specifically stimulated the growth of brain cortex tissue. The idea of tissue-specific bioregulators rests on this.4
  • In rats with a cut sciatic nerve the nerve fibres regrew 27 percent faster under Cortagen and conducted 40 percent faster. In rats with reduced blood flow in the brain behaviour recovered faster.38
  • In the hearts of mice 234 of 15,247 gene sequences studied changed their activity, that is 1.53 percent. What follows from this is open.2
  • No approval and no registered human trial, the data come almost entirely from one research line. Everything here is preclinical research, not a recommendation.101
Profile

Updated May 2026

Class
Short bioregulator peptide

Khavinson cytogen

Use
Subcutaneous

in mg

Target tissue
the brain cortex and nervous system
Status
Data mostly from the Khavinson program
Sizes
20 mg

1 size in the shop

Contents 15 sections
  1. At a glance
  2. What is Cortagen?
  3. How it works
  4. What you need
  5. Reconstitution
  6. Dosing
  7. Injection
  8. What the research shows
  9. Research status
  10. Side effects
  11. Storage
  12. Related compounds
  13. FAQ
  14. Glossary
  15. Sources

What is Cortagen?

Cortagen is a short peptide from the Russian Khavinson program, which deals with tissue-specific bioregulators. These very short peptides (usually 2 to 4 amino acids) are meant to act specifically on a particular tissue, Cortagen is aimed at the brain cortex and nervous system.

Up front: most research comes from a single research line and mostly from Russia, large independent studies are missing.

Comparison

Short peptides for brain and nerves

Cortagen next to other peptides related to the brain, as described in the TPD lexicon. Tap a card to open its entry.

How it works

The theory behind the Khavinson peptides: they are meant to act at the level of gene regulation and restart age-related declining functions of a tissue. For Cortagen a supportive effect on the brain cortex and nervous system is described.

How well this concept transfers to humans is little established outside the originating research.

Where it acts

Where Cortagen acted in experiments

Tap a point or a card. Grey = observed, no receptor is known. All from cell and animal studies.

  1. Brain cortex

    Brain cortex tissue cultures grew more (rats)4

    Observed in trials
  2. Sciatic nerve in the leg

    Fibres regrew 27% faster, conduction 40% faster (rats)3

    Observed in trials
  3. Heart

    234 gene sequences changed their activity (mice)2

    Observed in trials
  4. Immune cells

    IL-2 production in spleen cells stimulated, less than with Vilon and Epitalon (mice)5

    Observed in trials
Glass network of nerve cells with glowing DNA in the nucleus, two blue molecule chains releasing points of light towards the cell
Theory: action at the level of gene regulation in nerve tissue. Symbolic image.

What you need

Supplies

2 things, numbered as in the picture

Tick off what you already have. Vial and BAC water are our real shop photos at the same size.

Cortagen vial and bacteriostatic water at the same size with the black TPD label, next to two U-100 insulin syringes, two alcohol swabs and a sharps container with a blue lid
  1. Cortagen vial

    The vial (lyophilized powder, usually 20mg).

    In the shop
  2. Water and supplies

    Bacteriostatic water, U-100 insulin syringes, alcohol swabs.

    In the shop

Reconstitution

Use the peptide calculator. A 20mg vial with 2ml water gives 10mg per ml. Just add the water to the vial and let it dissolve.

Step by step

Dissolving the powder

Four steps, the same for every vial size.

  1. 1Wipe the cap

    Clean the rubber stopper with an alcohol swab.

  2. 2Add BAC water

    Just add it, it does not matter if it hits the powder directly.

  3. 3Swirl or shake

    Until everything has dissolved, both are fine.

  4. 4Draw up

    With the U-100 insulin syringe.

Less water higher concentration fewer units on the syringe Example: 20 mg + 2 ml = 10 mg/ml

Dosing

Dosing

Dosing, titration and syringe

Loading the dosing information …

  • Getting started and stepping up, drawn as a staircase
  • Units on the U-100 syringe for every step
  • How long one vial lasts

Injection

The injection is subcutaneous, into the fat layer under the skin. Common spots are the abdomen (keep about two finger-widths clear of the navel), the front and the inner side of the thigh, or the back of the upper arm.

The short version:

Injection

Where and at what angle

Pick a spot or switch the angle. Subcutaneous means: into the fat layer, not the muscle.

Rotate the spot each time, never the same one twice in a row.

90°More fat under the skin

Rule of thumb: where there is more fat under the skin, insert straight at 90 degrees. In lean people with little fat, 45 degrees, so the needle stays in the fat layer. Simplified diagram.

  1. Clean the spot with an alcohol swab and let it dry

  2. Pinch up a small fold of skin

  3. Insert the needle: at 90 degrees where there is more fat under the skin, at 45 degrees in lean people with little fat

  4. Inject slowly, wait a moment, then withdraw

  5. Put the needle straight into the sharps container

Rotate the site each time so the tissue does not get irritated. Never the same spot twice in a row.

What the research shows

The Khavinson program has published numerous works on tissue-specific bioregulators over decades (overview: Khavinson, 2002), including effects on organ function and, in animal models, on lifespan. But the read must stay honest: the data come mostly from one research line, large independent studies are missing.

Study results

What the trials measured

Interactive: switch tabs, tap points, show or hide arms. Arms are named relative to each other, no dosing advice.

Regrowing sciatic nerve3

Change compared with rats without Cortagen, in percent, after the nerve was cut and sutured, 10 days of dosing into the muscle

Growth rate of the fibres3
Without Cortagen (comparison) 0%
With Cortagen +27%
Conduction velocity3
Without Cortagen (comparison) 0%
With Cortagen +40%

Values according to the abstract. A single animal experiment from the research line that developed Cortagen. Not tested in humans in a registered trial.

Brain made of clear glass in front of a bright, blurred lab background
The data mostly come from one research group, large independent studies are missing. Symbolic image.

Research status

Where the research stands

From tissue cultures to animal experiments: what has been published on Cortagen. There is no registered human trial. As of 26 Oct 2026. 10

  1. Preclinical Tissue cultures, rats and mice
  2. Phase 1 no registered trial
  3. Phase 2 no registered trial
  4. Phase 3 no registered trial
  5. Approval not yet
Not approved and no registered human trial. The papers come almost entirely from the circle of the St. Petersburg Institute of Bioregulation and Gerontology.10

So far there is no registered trial in humans. 10

Side effects

  • Well tolerated in the available reports, mainly local reactions.
  • Solid, independent human safety data are limited.

Storage

Before mixing the powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. After mixing, keep in the fridge (2 to 8 degrees), do not freeze. It stays good there for at least 4 to 6 months with barely any loss of potency, in practice considerably longer. Swirl or shake to mix, both are fine.

Shelf life

How long it keeps

Undissolved (powder) Room temperature, around 20 to 25 degrees, dark

Robust, no fridge needed. Keeps for several months without trouble.

Dissolved (mixed) Fridge, 2 to 8 degrees, do not freeze

At least 4 to 6 months with barely any loss of potency. The bacteriostatic water brings a preservative.

  • Keep it dark
  • Dissolved: 2 to 8 degrees
  • Note the mixing date on the vial
Nine vials with white powder and blue caps in the door shelf of a bright fridge
Powder dark at room temperature, once dissolved into the fridge (2 to 8 degrees), stable there for at least 4 to 6 months. Symbolic image.

Related

Related compounds

Same groups or a different path: all in the TPD lexicon.

FAQ

Common questions about Cortagen

Short answers, each backed by the sources below.

Is Cortagen approved or studied in humans?

No. There is no approval and as of 26 October 2026 no trial with Cortagen in the registry ClinicalTrials.gov. The published papers are cell and animal experiments, almost all from one research line in St. Petersburg.101

Where does Cortagen come from?

From Vladimir Khavinson's programme of tissue-specific bioregulators. First came peptide extracts from animal tissue, for the brain cortex Cortexin. The synthetic tetrapeptide Ala-Glu-Asp-Pro was designed from their amino acid composition.12

What does tissue-specific mean?

In rat tissue cultures each of these short peptides mainly stimulated the tissue whose extract it was derived from. Cortagen promoted the growth of brain cortex tissue, Epitalon that of the brain structures below it, Livagen that of the liver, Vilon that of the thymus.4

What do the animal experiments show?

In rats with a cut and sutured sciatic nerve the fibres regrew 27 percent faster under Cortagen and conducted 40 percent faster. In rats with chronically reduced blood flow in the brain behaviour recovered faster and the oxidation of fats in the brain rose less. Another paper found fewer products of this oxidation in the blood and brain cortex.387

What is known about effects on genes?

After five days of Cortagen 234 of 15,247 gene sequences studied in the hearts of mice changed their activity (1.53 percent), assigned to 110 known genes. In blood cells of people aged 75 to 88 it loosened densely packed genetic material. Whether this leads to an effect in the body has not been tested.26

How is such a short peptide supposed to enter the cell?

That is unresolved. A computer analysis by the same research group suggests transporters such as LAT1 and the peptide transporters of the POT family. For Cortagen the calculated binding to LAT1 was weaker than for the transporter's natural partners.9

Which side effects are known?

There are no solid data because Cortagen has never been tested in a registered human trial. The entry mainly lists local reactions at the injection site, independent safety data are missing.10

Glossary

Terms explained briefly

Dotted words in the text open these explanations directly.

Bioregulator
Term from the Khavinson programme for peptides meant to act specifically on one tissue. The evidence comes mainly from tissue cultures and animal experiments.
Brain cortex
Outer layer of the cerebrum with the nerve cells for thinking, perception and movement.
Cortexin
Mixture of peptides obtained from the brain cortex of animals. The template for synthetic Cortagen.
Cytogen
Synthetic short peptide of two to four amino acids, designed from the composition of a tissue extract.
Gene regulation
Control of which genes in a cell are read and how strongly. The Khavinson peptides are meant to act here, which is shown only in the lab.
Khavinson programme
Decades of research by Vladimir Khavinson's group in St. Petersburg on peptide extracts and short peptides for single tissues.
Lyophilisate
Freeze-dried powder. Without water a peptide keeps much longer.
Preclinical
Research before first use in humans, in cell cultures and animal models. Results cannot be transferred directly to humans.
Subcutaneous
Into the fat layer just under the skin.
Tetrapeptide
A chain of exactly four amino acids. For Cortagen alanine, glutamic acid, aspartic acid and proline.

Evidence

Sources

Show all 11 sourcesHide sources 6 Studies1 Trial registry4 Database checked 26 Oct 2026

Studies

  1. Cortagen and the regrowing sciatic nerve (rats)

    Turchaninova et al., Bulletin of Experimental Biology and Medicine, 2000

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  2. Tissue-specific effects of short peptides (tissue culture, rats)

    Khavinson, Bulletin of Experimental Biology and Medicine, 2001

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  3. Short peptides and IL-2 in spleen cells (mice)

    Kazakova et al., Bulletin of Experimental Biology and Medicine, 2002

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  4. Short peptides and genetic material in blood cells of older people

    Khavinson et al., Bulletin of Experimental Biology and Medicine, 2004

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  5. Epitalon and Cortagen and the oxidation of fats (rats)

    Kozina, Bulletin of Experimental Biology and Medicine, 2007

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed
  6. Transport of short peptides into the cell, computer analysis

    Khavinson et al., International Journal of Molecular Sciences, 2022

    Checked 26 Oct 2026 via doi.org, Crossref, PubMed, PMC (Volltext)

Trial registry

  1. Search on ClinicalTrials.gov (no trial with Cortagen)

    ClinicalTrials.gov, U.S. National Library of Medicine

    Checked 26 Oct 2026 via ClinicalTrials.gov API v2

Database

  1. Review: peptides and ageing, the Khavinson programme (PubMed record)

    Khavinson, Neuro Endocrinology Letters, 2002 (ohne DOI)

    Checked 26 Oct 2026 via PubMed
  2. Cortagen and gene activity in the hearts of mice (PubMed record)

    Anisimov et al., Neuro Endocrinology Letters, 2004 (ohne DOI)

    Checked 26 Oct 2026 via PubMed
  3. Cortexin and Cortagen in reduced brain blood flow (rats, PubMed record)

    Zarubina und Shabanov, Eksperimental'naia i Klinicheskaia Farmakologiia, 2011 (russisch, ohne DOI)

    Checked 26 Oct 2026 via PubMed
  4. Structure of Cortagen in PubChem

    PubChem, U.S. National Library of Medicine (CID 18439621)

    Checked 26 Oct 2026 via PubChem

In the shop

Cortagen in the catalog

Sizes, prices and shipping times are on the product page.

To the product